跳至主要内容
临床试验/NCT05847634
NCT05847634招募中不适用

Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis

University of Manitoba1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Recruitment

研究概览

简要总结

Investigation of the feasibility of monitoring processed transcutaneous electroencephalography (EEG), a method of interpreting brain activity, and near-infrared spectroscopy (NIRS), a method of determining levels of tissue oxygenation (StO2) in the brain, for patients with acute respiratory distress syndrome (ARDS) in the ICU.

详细描述

The aim of this study is to determine the feasibility of using Masimo SedLine processed EEG monitoring and Masimo O3 NIRS to monitor optimal depth of sedation for patients with ARDS in the ICU.

To achieve this, non-invasive devices will be applied to the participant to measure processed EEG signal and StO2. Cerebrovascular reactivity will be determined using the following two values:

  1. SEDopt: The optimal depth of sedation that minimizes correlation between StO2 and processed EEG monitoring.
  2. MAPopt: The optimal blood pressure that minimizes correlation between StO2 and MAP.

Demographic information (age, sex, height, weight), past medical history, etiology of ARDS, Disease severity, routine bloodwork, and dose of sedation will also be documented.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient admitted to the ICU
  • ARDS confirmed according to the Berlin Definition
  • Invasive mechanical ventilation
  • Deep sedation and/or neuromuscular blockade required for ARDS treatment at the discretion of the treating medical team
  • Application of monitoring devices feasible

排除标准

  • More than 24 hours elapsed since ICU admission
  • Death is deemed imminent and inevitable during the next 24 hours
  • Known allergy to a textile component of the device
  • Consent declined from patient or authorized third party
  • The treating clinician believes that participation in the study would not be in the best interest of the patient

结局指标

主要结局

Recruitment

时间窗: 20 months

Recruitment of two patients per month, allowing for seasonal variation in ARDS.

Data Quality

时间窗: 7 days

Physiologic signal with greater than 80% data quality to allow for calculation of SEDopt

次要结局

  • SEDopt(7 days)
  • MAPopt(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asher Mendelson

Assistant Professor

University of Manitoba

研究点 (1)

Loading locations...

相似试验

Depth of Sedation and Its Impact on Cerebrovascular... | 临床试验